VALOR: Vaginal Atrophy & Long-term Observation of Recovery
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Stratpharma AG
- Study ID
- NCT05953090
- Status
- Recruiting
Conditions
- Atrophic Vaginitis
- Genitourinary Syndrome of Menopause
- Lichen Planus of Vulva
- Lichen Sclerosus of Vulva
- Lichen Simplex of Vulva (Disorder)
- Vaginal Atrophy
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 7-0940 — DEVICEA non-hormonal and non-steroidal gel that supports vulvovaginal mucosal conditions and speeds up recovery post vaginal rejuvenation. It is a suitable alternative to vaginally administered estrogen and topical corticosteroids, that promotes a moist healing environment leading to faster re-epithelialization. The gel relieves symptoms such as itchiness, tenderness, dryness, burning sensation, painful intercourse (dyspareunia), painful urination (dysuria), rectal and defecating pain. It improves erythema, mucosal tissue thinning, erosions, fissures, ulcerations, scarring/adhesions and swelling. It is indicated for long-term use to maintain the health of the vaginal mucosa without the side effects of vaginally administered hormonal therapy and topical corticosteroids.
Study Details
Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will be treated with a novel gel dressing to test the short- and long-term safety and efficacy of the device.
Key Dates
- Start date
- Oct 30, 2023
- Status verified
- Feb 2026
- Primary completion
- Jun 30, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 2,000 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Feasibility
Primary Outcome Measure
Change in Vulvovaginal Symptoms Questionnaire (VSQ) score from baseline at 12 months. [ Time Frame: 12 months ]
Locations (14)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Cahaba Dermatology & Skin Health Center | Birmingham | Alabama | 35244 | |
| Velvet Clinical Research | Burbank | California | 91506 | |
| Orange Coast Women's Medical Group | Laguna Hills | California | 92653 | - |
| WR-PRI, LLC (Los Alamitos) | Los Alamitos | California | 90720 | Yasmin Herring, MD (PRINCIPAL_INVESTIGATOR) |
| WR-PRI, LLC (Newport Beach) | Newport Beach | California | 92660 | Susan Park, MD (PRINCIPAL_INVESTIGATOR) |
| WR-Women's Health Care Research, LLC | San Diego | California | 92111 | Robert Semo, MD (PRINCIPAL_INVESTIGATOR) |
| WR-Multi-Specialty Research Associates | Lake City | Florida | 32055 | Cynthia Magrini, MD (PRINCIPAL_INVESTIGATOR) |
| WR-Mount Vernon Clinical Research, LLC | Sandy Springs | Georgia | 30328 | Gretchen Mitchell, MD (PRINCIPAL_INVESTIGATOR) |
| WR-Clinical Research Center of Nevada, LLC | Las Vegas | Nevada | 89106 | Liliana Ruiz-Leon, DO (PRINCIPAL_INVESTIGATOR) |
| WR-Carolina Institute for Clinical Research | Fayetteville | North Carolina | 28303 | Connette McMahon, MD (PRINCIPAL_INVESTIGATOR) |
| WR-Charleston Clinical Trials, LLC | Charleston | South Carolina | 29414 | Donald Hurley, DO (PRINCIPAL_INVESTIGATOR) |
| Southern Urogynecology | West Columbia | South Carolina | 29169 | Andrea Pezzella, MD (PRINCIPAL_INVESTIGATOR) |
| WR-Medical Research Center of Memphis, LLC | Memphis | Tennessee | 38210 | Todd Chappell, MD (PRINCIPAL_INVESTIGATOR) |
| WR-Global Medical Research, LLC | Dallas | Texas | 75224 | Roxanne Pero, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Birmingham, AL
By condition
By specialty
By research site
Related Studies
- Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of MenopauseRecruiting · Stratpharma AG · Laguna Hills, California
- Vaginal Ecosystem and Network in the United States StudyEnrolling By Invitation · Vaginal Biome Science · Fullerton, California
- Vaginal Changes After CO2 LaserRecruiting · University of California, Irvine · Irvine, California
- ASSIST-VLA: Assessment of Symptom-Specific Improvement in Diagnosed Vaginal Atrophy Following Laser TherapyPHASE4 · Recruiting · Stratpharma AG · Laguna Hills, California